SILVERARC CAPITAL MANAGEMENT, LLC

Position in BNTC — Benitec Biopharma Inc.

CIK 1816307 BOSTON, MA

Position in BNTC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,096,071

+$1,452,300 QoQ

Shares Held

679,826

-5.3% QoQ

Ownership

1.98%

of shares outstanding

% of Portfolio

1.01%

of 13F equity value

Holder Rank

#13

of 86 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. BNTC ranks #28 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	206,234	$55,006,732
2	CELC	Celcuity Inc.	500,996	$52,414,201
3	COGT	Cogent Biosciences, Inc.	1,280,707	$49,563,360
4	URGN	UroGen Pharma Ltd.	1,301,979	$47,912,827
5	IMNM	Immunome Inc.	2,017,009	$42,740,420
6	DNTH	Dianthus Therapeutics, Inc. /DE/	390,000	$38,017,200
7	RYTM	Rhythm Pharmaceuticals, Inc.	311,461	$34,581,514
8	ORKA	Oruka Therapeutics, Inc.	352,802	$33,576,166

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,096,071	679,826	-5.3%	Shares	Sole	2026-08-13
2026-03-31	$7,643,771	717,725	-1.9%	Shares	Sole	2026-05-14
2025-12-31	$9,856,227	731,717	+164.9%	Shares	Sole	2026-02-12
2025-09-30	$3,876,026	276,267	+9.1%	Shares	Sole	2025-11-12
2025-06-30	$2,962,837	253,234	+1.3%	Shares	Sole	2025-08-14
2025-03-31	$3,252,500	250,000	-49.3%	Shares	Sole	2025-05-14
2022-03-31	$57,000	492,880	-16.1%	Shares	Sole	2022-05-13
2021-12-31	$1,539,247	587,499	+18.0%	Shares	Sole	2022-02-14
2021-09-30	$1,777,892	498,009	+6.6%	Shares	Sole	2021-11-15
2021-06-30	$1,985,838	467,256	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.